FDG-PET/CT in staging of clear cell odontogenic carcinoma

Int J Oral Maxillofac Surg. 2014 Nov;43(11):1326-9. doi: 10.1016/j.ijom.2014.06.008. Epub 2014 Jul 9.

Abstract

Clear cell odontogenic carcinoma (CCOC) is a rare neoplasm; only 75 cases have been reported in the English language literature. They have a tendency for recurrence and a capacity to metastasize. There is very little known regarding the metabolic features of this tumour or the utility of fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) scans in the staging and follow-up of these tumours. We present two cases of CCOC with their relevant FDG-PET/CT scan findings. The first patient had primary CCOC of the mandible that was FDG-avid, and the other had recurrence of CCOC of the anterior mandible and superomedial orbit that was not FDG-avid. FDG uptake in CCOC appears to be variable. Although FDG-PET/CT is useful in other head and neck cancers and has benefits compared to other imaging modalities, further studies are needed to investigate the sensitivity of FDG-PET/CT in CCOC.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Biopsy
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Lymphatic Metastasis
  • Mandibular Neoplasms / diagnostic imaging*
  • Mandibular Neoplasms / pathology
  • Mandibular Neoplasms / surgery
  • Maxillary Neoplasms / diagnostic imaging*
  • Maxillary Neoplasms / pathology
  • Maxillary Neoplasms / surgery
  • Middle Aged
  • Multimodal Imaging*
  • Neoplasm Staging
  • Odontogenic Tumors / diagnostic imaging*
  • Odontogenic Tumors / immunology*
  • Odontogenic Tumors / pathology
  • Odontogenic Tumors / surgery
  • Orbital Neoplasms / diagnostic imaging*
  • Orbital Neoplasms / pathology
  • Orbital Neoplasms / surgery
  • Positron-Emission Tomography / methods*
  • Radiopharmaceuticals
  • Tomography, X-Ray Computed / methods*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18